Biocon to deliver advanced cancer therapies across 30 countries
Biocon to deliver advanced cancer therapies across 30 countries
05 February 2021 | News
Image Credit: shutterstock.com
Biocon Biologics Ltd, a fully integrated ‘pure play’ biosimilars company and a subsidiary of Biocon Ltd has signed an agreement with the Clinton Health Access Initiative (CHAI) to expand access to lifesaving cancer biosimilars in over 30 countries in Africa and Asia as a part of the Cancer Access Partnership (CAP). The partnership is a significant step in delivering advanced cancer therapies to patients who need them the most and ensuring equitable access to high-quality biosimilars in low- and middle-income countries (LMICs).
Explore Now
Nifty futures trading on the Singapore Exchange were up 77.05 points or 0.52 per cent at 14,970.80, at 7:45 am, in signs of a positive start for Dalal Street on Friday. Here are a few stocks which may buzz the most in today s trade:
Q3 earnings: M&M, Pfizer, PNB, Alkem Laboratories, Aditya Birla Capital, Ashoka Buildcon, Britannia, Cadila Healthcare, Equitas Holdings, Fortis Healthcare, GlaxoSmithkline Pharma, Gujarat Gas and Jubilant Life Sciences will be reporting their financial results for the October-December period on Friday.
Other companies that will be posting their Q3 earnings include Narayana Hrudaya, SKF India, TCNS Clothing, Mrs. Bectors Food Specialities, Cholamandalam Financial Holdings, Kolte Patil Developers, NIIT, Privi Speciality Chemicals, Rashtriya Chemicals & Fertilizers, Shipping Corp and Sumitomo Chemical.
Williams Babalola
The Federal Government of Nigeria has okayed 12 hospitals for cancer treatment in the ongoing Cancer Access Partnership Programme.
The hospital is aimed at over 50 per cent cost reduction, the Minister of Health, Osagie Ehanire, disclosed in Abuja on Thursday during the World Cancer Day.
He reiterated the commitment of the Federal Ministry of Health under his watch to improve access to cancer care services, especially in diagnosis, chemotherapy and radiotherapy services.
He said the ministry is currently improving services in some hospitals across the country, with installation of radiotherapy machines already in advanced stages in UNTH Enugu, UBTH Benin, UDUTH Sokoto, UCH Ibadan and ABUTH Zaria.
Biocon Biologics to offer its Oncology Biosimilars through Cancer Access Partnership in over 30 countries
Posted On: 2021-02-04 04:58:01 (Time Zone: Arizona, USA)
Biocon Biologics Ltd., a fully integrated pure play biosimilars company and a subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), has signed an agreement with the Clinton Health Access Initiative (CHAI) to expand access to lifesaving cancer biosimilars in over 30 countries in Africa and Asia as a part of the Cancer Access Partnership (CAP). The partnership is a significant step in delivering advanced cancer therapies to patients who need them the most and ensuring equitable access to high-quality biosimilars in low- and middle-income countries (LMICs).